Ocular Therapeutix Inc.
OCUL | NASDAQ
$6.92
-$0.05 (-0.72%)
Nov 2, 2026, 10:35 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 737.06M | 392.1M | 195.81M | 102.3M | 164.16M | 228.06M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.61M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 1.61M | 1.61M | 1.76M | 1.76M | 1.76M |
Receivables | 30.65M | 32.39M | 26.18M | 21.33M | 21.14M | 12.25M |
Inventory | 3.56M | 3.04M | 2.31M | 1.97M | 1.25M | 1.2M |
Other Current Assets | 10.86M | 13.46M | 7.94M | 4.03M | n/a | n/a |
Total Current Assets | 782.13M | 440.99M | 232.24M | 129.63M | 191.3M | 246.16M |
Property-Plant & Equipment | 24.31M | 15.33M | 18.21M | 17.9M | 11.82M | 13.94M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 25.93M | 16.95M | 19.83M | 19.66M | 13.59M | 15.7M |
Total Assets | 808.06M | 457.94M | 252.06M | 149.29M | 204.89M | 261.86M |
Account Payables | 4.15M | 4.18M | 4.39M | 5.12M | 4.59M | 2.71M |
Deferred Revenue | n/a | 128K | 255K | 576K | n/a | n/a |
Short-Term Debt | 2.82M | n/a | n/a | n/a | n/a | 8.29M |
Other Current Liabilities | 25.86M | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 50.81M | 41.35M | 34.9M | 31.4M | 26.34M | 26.66M |
Long-Term Debt | 74.15M | 68.51M | 74.93M | 54.01M | 51.44M | 41.24M |
Other Long-Term Liabilities | 11.98M | 13.39M | 30.1M | 6.44M | 20.19M | 98.31M |
Total Long-Term Liabilities | 102.94M | 101.24M | 126.03M | 82.52M | 90.55M | 159.1M |
Total Liabilities | 153.75M | 142.59M | 160.93M | 113.91M | 116.89M | 185.77M |
Total Debt | 79.78M | 75.78M | 83.39M | 64.28M | 58.98M | 58.44M |
Book Value | 654.31M | 315.34M | 91.13M | 35.38M | 88M | 76.1M |
Book Value Per Share | 3.49 | 1.99 | 1.06 | 0.43 | 1.07 | 1.25 |
Common Stock | 22K | 16K | 12K | 8K | 8K | 8K |
Retained Earnings | -1.16B | -891.08M | -697.58M | -616.84M | -545.8M | -539.25M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 654.31M | 315.34M | 91.13M | 35.38M | 88M | 76.1M |
Total Investments | 1.61M | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove OCUL